Dapagliflozin, a drug commonly used to treat type 2 diabetes, improved heart failure-related symptoms and physical limitations in patients with heart failure with preserved ejection fraction.
Browsing: Preventive Medicine
Donald Lloyd-Jones, MD, ScM, chair of Preventive Medicine and the Eileen M. Foell Professor of Heart Research, and current president of the American Heart Association, recently testified before Congress in support of legislation that would improve cardiovascular health in the U.S.
Epigenetic aging could serve as a promising biomarker for measuring long-term cardiovascular health and disease risk, according to a recent Northwestern Medicine study.
Thirty-five years since it was started, the Coronary Artery Risk Development in Young Adults study, or CARDIA, has become a premier source for the determinants, mechanism and outcomes of cardiovascular disease and manifestations of aging.
A mental health smartphone app developed by a team of Northwestern Medicine investigators helped improve depressive symptoms in patients with diabetes and hypertension, according to a recent clinical trial published in JAMA.
Northwestern Medicine scientists and clinicians have continued to investigate methods to combat the disease, including strategies to conduct clinical trials during a pandemic, studying neurologic symptoms in children and reflecting on the importance of professional medical organizations during a public health crisis.
Starting cholesterol-lowering treatment earlier may increase the its benefits, reducing heart attack and stroke over time, according to a Northwestern Medicine study.
African Americans who were exposed to segregation in their neighborhoods during young adulthood are more likely to have poor cognitive performance as early as midlife.
Drinking flavanol-rich cocoa three times a day improved walking distance in individuals with peripheral artery disease, reports a new Northwestern Medicine pilot study published in Circulation Research.
Considered the founding father of preventive cardiology, Jeremiah Stamler, MD, who celebrated his 100th birthday Oct. 27, is still conducting ‘brilliant science,’ according to his colleagues.